Related Experiment Videos
Idiopathic myelofibrosis in children
M Sekhar1, H G Prentice, U Popat
1BMT Programme, Royal Free Hospital and Medical School, London, UK.
British Journal of Haematology
|May 1, 1996
Summary
Childhood myelofibrosis (Mf) is rare and presents differently in children than adults. Allogeneic bone marrow transplant (BMT) offers a potential definitive treatment for severe cases.
Area of Science:
- Pediatric Hematology
- Oncology
- Genetics
Background:
- Childhood myelofibrosis (Mf) is a rare hematologic disorder with poorly understood etiology and variable clinical outcomes.
- Idiopathic Mf in early childhood presents a unique clinical challenge, differing from adult presentations.
Observation:
- Three children with idiopathic Mf were studied; two were identical twins who remained stable for 7 years post-diagnosis.
- The third patient, experiencing clinical deterioration, successfully underwent allogeneic bone marrow transplant (BMT) and remains engrafted at 13 months.
- Hepatosplenomegaly was absent, but extramedullary hemopoiesis was detected in two patients via 52Fe studies.
Findings:
- Patients exhibited increased circulating progenitors alongside reduced marrow precursors, suggesting altered hematopoiesis.
- The natural history of childhood Mf appears distinct from the adult form of the disease.
Implications:
- Allogeneic bone marrow transplant (BMT) is a viable therapeutic option for severe childhood myelofibrosis.
- Further research into the etiology and distinct natural history of pediatric Mf is warranted.